F · Healthcare

ONDINE BIOMEDICAL INC.CDI (VF5)

Biotechnology

ONDINE BIOMEDICAL INC.CDI (VF5) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for VF5

P/E ratio

25.00

ONDINE BIOMEDICAL INC.CDI (VF5) — FAQ

What is VF5's P/E ratio?

The price-to-earnings (P/E) ratio for ONDINE BIOMEDICAL INC.CDI (VF5) is 25.00 (data as of 2026-05-21).

Does ONDINE BIOMEDICAL INC.CDI pay a dividend?

Dividend yield is not available in the current snapshot for ONDINE BIOMEDICAL INC.CDI (VF5). Check the MyAverix Finance app for the latest dividend data.

What sector is ONDINE BIOMEDICAL INC.CDI in?

ONDINE BIOMEDICAL INC.CDI (VF5) is classified in the Healthcare sector (Biotechnology industry).

What exchange is VF5 listed on?

VF5 is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)